<h3>Gainers</h3>
<ul>
<li>Quince Therapeutics (NASDAQ:QNCX) stock increased by 158.9% to $0.34 during Tuesday's regular session. The market value of their outstanding shares is at $7.2 million. </li>
<li>Phio Pharma (NASDAQ:PHIO) stock rose 51.11% to $1.36. The market value of their outstanding shares is at $9.6 million. </li>
<li>Evommune (NYSE:EVMN) stock moved upwards by 44.7% to $24.59. The company's market cap stands at $535.5 million. </li>
<li>Nektar Therapeutics (NASDAQ:NKTR) shares increased by 42.97% to $53.0. The company's market cap stands at $754.0 million. </li>
<li>Abpro Hldgs (NASDAQ:ABP) shares rose 27.63% to $1.94. The company's market cap stands at $4.1 million. </li>
<li>BiomX (AMEX:PHGE) stock moved upwards by 24.7% to $5.65. The market value of their outstanding shares is at $6.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>BioRestorative Therapies (NASDAQ:BRTX) shares declined by 33.0% to $0.7 during Tuesday's regular session. The market value of their outstanding shares is at $9.2 million. </li>
<li>Ensysce Biosciences (NASDAQ:ENSC) shares fell 25.79% to $0.45. The company's market cap stands at $2.1 million. </li>
<li>Tectonic Therapeutic (NASDAQ:TECX) shares decreased by 20.96% to $19.63. The company's market cap stands at $464.7 million. </li>
<li>Becton Dickinson (NYSE:BDX) shares declined by 17.38% to $171.35. The market value of their outstanding shares is at $59.0 billion. As per the press release, Q1 earnings came out yesterday. </li>
<li>Medpace Hldgs (NASDAQ:MEDP) stock fell 14.95% to $451.08. The company's market cap stands at $14.9 billion. As per the press release, Q4 earnings came out yesterday. </li>
<li>Regenxbio (NASDAQ:RGNX) stock fell 14.55% to $8.81. The company's market cap stands at $521.9 million. 
See Also: www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MEDP

EVMN

NKTR

PHIO

QNCX

In Tuesday's intraday session, Quince Therapeutics (NASDAQ:QNCX) saw a significant gain of 158.9%, reaching $0.34, while Phio Pharma (NASDAQ:PHIO) rose 51.11% to $1.36. Other notable gainers included Evommune (NYSE:EVMN) up 44.7% and Nektar Therapeutics (NASDAQ:NKTR) up 42.97%. Conversely, BioRestorative Therapies (NASDAQ:BRTX) experienced a decline of 33.0%, and Ensysce Biosciences (NASDAQ:ENSC) fell 25.79%. Becton Dickinson (NYSE:BDX) shares dropped 17.38% to $171.35, and Medpace Hldgs (NASDAQ:MEDP) fell 14.95% following Q1 earnings release.

12 Health Care Stocks Moving In Tuesday's Intraday Session